Osseus’ 3D Printed Spine Anchors Receive FDA Clearance
The company says the system can be used with both bone screws and alternative fixation bone anchors to enable increased intraoperative flexibility, expulsion resistance and segmental stabilization.
The Pisces-SA is a standalone ALIF platform integrating a highly porous 3D printed interbody system. Photo Credit: Osseus
Osseus, a spinal solutions company, has earned FDA 510(k) clearance for its Pisces-SA Standalone Anterior Lumbar Interbody Fusion (ALIF) Interbody System. The company says the system can be used with both bone screws and alternative fixation bone anchors to enable increased intraoperative flexibility.
According to the company, biomechanical testing proved that the Pisces-SA anchors provide better expulsion resistance and perform comparably with traditional screw-based standalone ALIF constructs in stabilizing injured spinal segments. It is said the system is the first of its kind to provide this level of expulsion resistance and segmental stabilization using an alternative fixation method.
The anchors are said to enable a streamlined, direct anterior approach which facilitates minimal access and improved operational efficiency and versatility.
“I’ve used screws […], and I’ve used the blade-type constructs, but I’ve never used a device where you could make that choice intraoperatively. I really like that ability to make my decision at the time,” says Dr. Michael Hisey, an orthopedic surgeon with the Texas Back Institute in Plano, Texas.
This platform is said to integrate a highly porous 3D printed interbody with anatomical morphology designed for full osseointegration with streamlined instrumentation to facilitate a minimally invasive approach. Osseus says the Pisces-SA sets the new standard for standalone ALIF devices.
“Receiving FDA approval for the Pisces-SA is the culmination of relentless work from our R&D department and surgeon design team,” says Rob Pace, Osseus founder and CEO. “Since our inception, we have pushed the envelope, creating minimally invasive products to help simplify and streamline procedures. This product hits that mark, and we are excited to introduce it to the market.”
Related Content
-
PrinterPrezz/Vertex Manufacturing Rebrands to Zeda
The rebranding is said to reflect the company’s “Z to A” approach, which means it starts first with the customer in mind and ends with a product.
-
New Zeda Additive Manufacturing Factory in Ohio Will Serve Medical, Military and Aerospace Production
Site providing laser powder bed fusion as well as machining and other postprocessing will open in late 2023, and will employ over 100. Chief technology officer Greg Morris sees economic and personnel advantages of serving different markets from a single AM facility.
-
Production AM Demands Process and Procedures — More Machines Will Come Later
Arch Additive has transitioned to full production of implants made through electron beam melting. The transition has involved practices and personnel, not equipment. As customer products win approval and go to market, here are 5 operational moves the AM implant manufacturer has made.